Evidence map›Paper›PMID 31463286›Full record

ArticleJournal of family medicine and primary care2019

Mortality in systemic lupus erythematosus at a teaching hospital in India: A 5-year retrospective study.

Gangadharaiah Bharath, Prabhat Kumar, Nayani Makkar, Paras Singla, Manish Soneja, Ashutosh Biswas, Naveet Wig

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of family medicine and primary care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06618573 (Study on the Safety of Administering Isoniazid to Systemic Lupus Erythematosus Patients to Prevent Tuberculosis), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06618573 phase2 / phase3recruitingnot on this mapstarted 2022, after this paper: background citation

Study on the Safety of Administering Isoniazid to Systemic Lupus Erythematosus Patients to Prevent Tuberculosis

TypeinterventionalSponsorUniversitas PadjadjaranRan2022 to 2025Enrolled60ConditionsTuberculosis, Systemic Lupus ErythematosusArmsIsoniazid/Pyridoxine, Saccharum Lactis
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Systemic lupus erythematosus-myositis overlap syndrome with lupus nephritis.Journal of family medicine and primary care · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gangadharaiah BharathDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Prabhat KumarDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Nayani MakkarDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Paras SinglaDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Manish SonejaDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Ashutosh BiswasDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Naveet WigDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSystemic lupus erythematosus (SLE) is an autoimmune disease with an unknown etiology that can be life threatening. This study aimed to study the cause of mortality among admitted SLE patients over a period of 5 years at a teaching hospital in India.

methodsA 5-year retrospective analysis of mortality in SLE patients admitted under department of medicine of our institute was done. The presenting complaints, treatment history, clinical parameters, laboratory investigations, organ involvement, systemic lupus erythematosus disease activity index (SLEDAI), and cause of mortality were collected from the medical records on a predesigned proforma. A further analysis of two groups based on the cause of mortality was done.

resultsIn total, 53 death records were analyzed. Mortality in 28 SLE patients was due to high disease activity (Group I) and mortality in 25 patients was attributed due to both high disease activity and concomitant infection (Group II). Most of the patients were female (98%) and mean age of patient was 30.6 years. About 19 patients (35.8%) were diagnosed with SLE during hospital admission. Fever was the most common presenting complaint (69.8%) and lupus nephritis was the most common organ dysfunction seen (84.9%). Myocarditis was observed in 11 patients and 9 patients had cerebrovascular accident. The mean hemoglobin was lower in Group II (7.4 vs. 8.7 g/dL,

conclusionMortality among SLE patients could be due to disease flare or concomitant infection. Lung is the most common organ affected by infection in these patients.

Indexed as

Anti phospholipid syndromeinfectionlupus nephritismyocarditisposterior reversible encephalopathy syndrome

Identifiers

PMID31463286
PMCPMC6691451
OpenAlexW2964905828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.